Sunnyvale, CA, United States of America

Noelene E Byars


Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 138(Granted Patents)


Company Filing History:


Years Active: 1986-1994

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Noelene E. Byars in Vaccine Development**

Introduction

Noelene E. Byars, an accomplished inventor based in Sunnyvale, CA, has made significant strides in the field of vaccine technology. With a remarkable portfolio of five patents, her innovations have contributed to advancements in immunology, particularly in the development of vaccine adjuvants and feline leukemia virus vaccines.

Latest Patents

One of her noteworthy inventions is a vaccine adjuvant, which is designed as an emulsion that includes a non-toxic tetra-polyol or a block polymer. This groundbreaking composition is critical for enhancing the immune response when delivering antigens. Specifically, it comprises a muramyldipeptide and aims to provide a more effective immunologic defense against various pathogens. Additionally, her patents cover methods of preparing this adjuvant and a kit for its extemporaneous preparation.

Another significant patent focuses on a vaccine for immunizing animals against Feline Leukemia Virus (FeLV). This innovative vaccine utilizes an FeLV antigen emulsified with a specialized block polymer, surfactants, and an immunostimulating glycopeptide, allowing for a potent immunological response in affected animals.

Career Highlights

Throughout her career, Noelene has demonstrated a commitment to developing solutions that address healthcare needs through her work at Syntex (U.S.A.) Inc. Her innovative approach to vaccine formulation and immunology has garnered recognition in the scientific community.

Collaborations

Noelene has collaborated with esteemed colleagues Anthony C. Allison and Cherng-chyi Fu, enhancing the research and development processes. These partnerships have proven successful in pushing the boundaries of vaccine development, leading to life-saving innovations.

Conclusion

Noelene E. Byars has established herself as a prominent figure in the field of vaccine research and development. Her patented innovations reflect her dedication to advancing healthcare solutions through effective immunization strategies. As the industry progresses, Byars' contributions will undoubtedly continue to play a vital role in battling infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…